Malvidin

Malvidin

1. Identity, Chemical Classification, and Common Names

Malvidin is a naturally occurring plant pigment belonging to the anthocyanidin subclass of flavonoids. It is an O-methylated anthocyanidin, specifically the 3′,5′-methoxy derivative of delphinidin. Structurally, most anthocyanins are water-soluble glycosides and chemically are derivatives of the 2-phenylbenzopyrylium or flavylium salts, and malvidin's aglycone form carries a flavylium (benzopyrylium) core that is substituted with two methoxy groups at positions 3′ and 5′ on its B-ring. The molecular formula of the malvidin cation is C₁₇H₁₅O₇⁺ (PubChem CID 159287), and the chloride salt (malvidin chloride) has the molecular formula C₁₇H₁₅ClO₇ with the registered CAS number 643-84-5.

The compound is known by multiple synonyms in the chemical and botanical literature. These include oenidin, syringidin, malvidol, malvinidin, enidin, and primulidin. The term anthocyanin refers to a glycoside, while anthocyanidin refers to the aglycone. The most common and studied glycoside of malvidin is malvidin-3-O-glucoside, also known as oenin, which is the 3-O-glucoside of malvidin.

Approximately 23 aglycones have been identified and characterized; however, only six are widely distributed among plants, namely cyanidin, delphinidin, malvidin, pelargonidin, peonidin, and petunidin. Malvidin is distinguished from other anthocyanidins by the two methoxy groups on its B-ring, which confer distinctive photochemical and metabolic properties relative to its parent compound delphinidin.

Slightly acidic and neutral solutions of malvidin are characteristically of a red color, while basic solutions of malvidin yield a blue color. Anthocyanins are more stable in acidic solutions (pH 1–3), where they exist as flavylium cations.

2. Botanical Sources and Natural Occurrence

Malvidin is an O-methylated anthocyanidin responsible for the blue-red color found in flowers and fruits, and its distribution covers a wide group of sources, such as flowers (edible and nonedible), medicinal plants, and fruits. It is the main substance responsible for the color of red grapes and red wine, with Vitis vinifera being one of its main sources.

The principal botanical and food sources of malvidin and its glycosides include:

• Red grapes (Vitis vinifera): The most studied vitisins are those formed from malvidin-3-O-glucoside, the anthocyanin with the highest concentration in wines. In particular, malvidin-3-O-glucoside accounts for 49.17%, 32.52%, and 49.88% of the relative peak area of grape skin decoction, soxhlet, and microwave extracts, respectively.
• Red wine: In red wines from Vitis vinifera grapes, the main monomeric anthocyanins are malvidin-3-O-glucoside, cyanidin-3-O-glucoside, delphinidin-3-O-glucoside, pelargonidin-3-O-glucoside, peonidin-3-O-glucoside, and petunidin-3-O-glucoside. Malvidin-3-O-glucoside is the predominant of these.
• American grape species (Vitis labrusca): The derivative malvidin-3,5-diglucoside is mainly found in grape varieties of the American species Vitis labrusca. This substance is not detectable in European Vitis vinifera varieties, which contain only the derivative malvidin-3-glucoside.
• Blueberries and bilberries (Vaccinium spp.): Malvidin is also present in berries such as blueberries (Vaccinium corymbosum) and the saskatoon berries (Amelanchier alnifolia). In bilberry, acid hydrolysis identifies five major anthocyanidin aglycones including malvidin.
• Primula (polyanthus group): Malvidin is responsible for the blue color found in petals of the Primula plants of the polyanthus group.
• Blue pimpernel (Anagallis monelli): Blue flowers of the blue pimpernel (Anagallis monelli) also have a higher concentration of malvidin.
• Amur grape (Vitis amurensis): Vitis amurensis Rupr. "Beibinghong" is abundant in anthocyanins, including malvidin (Mv), malvidin-3-glucoside (Mv3G), and malvidin-3,5-diglucoside (Mv35G).

These colored constituents occur in various berries and fruits of the genera representing Prunus, Vaccinium, Vitis, Ribes, Morus, Fragaria, Aronia, and Rubus.

3. Common Forms and Glycosides

Malvidin rarely occurs as a free aglycone in nature. As a primary plant pigment, its glycosides are highly abundant in nature. The glycoside forms are created when a sugar moiety (most commonly glucose, but also galactose, arabinose, or others) is attached to the hydroxyl group at the C-3 position on the anthocyanidin core. The principal forms include:

• Malvidin-3-O-glucoside (oenin): The predominant anthocyanin in Vitis vinifera-derived red wines and a widely studied bioactive compound. It is one of the red pigments found in purple grape skins and red wine.
• Malvidin-3-O-galactoside: Found in berries, including bilberry and blueberry, and frequently quantified alongside malvidin-3-glucoside in pharmacological research. Generally, malvidin-3-glucoside exerts a more powerful effect than malvidin-3-galactoside in antioxidant and anti-inflammatory processes.
• Malvidin-3,5-O-diglucoside: Malvidin-3,5-O-diglucoside (Mv 3,5-diglc) is a sugar derivative of malvidin found predominantly in Vitis labrusca grapes.
• Acylated derivatives: These anthocyanins are also present in acylated forms with acetic, coumaric, and caffeic acids.

Anthocyanins extracted from plants have been used as food additives. Food additive E163 is one of the commercial additives derived from fruit anthocyanin such as grape skin, used as a purple food additive for jam, confectionaries, and beverages. Anthocyanins including malvidin and its glycosides offer appealing colors of red, purple, and blue, are naturally abundant, and pose no harm to consumers, making them desirable as natural color additives. However, their limited stability, especially in comparison to artificial dyes, has restricted their widespread utilization.

4. Traditional and Historical Use

Malvidin was not traditionally identified as a discrete chemical compound; rather, the plants and beverages richest in malvidin — principally red grapes, red wine, bilberries, and other darkly pigmented fruits — carry extensive histories of use across multiple cultures.

4.1 Ancient Egyptian Use

A particularly notable historical marker for malvidin comes from archaeochemistry. The breakdown of malvidin releases syringic acid, as revealed in the examination of jars containing shedeh, a drink of Ancient Egypt. This represents the earliest documented chemical evidence of malvidin-containing beverages, identifying grape-derived anthocyanins as components of ancient Egyptian elite beverages.

4.2 Grapes and Red Wine in Mediterranean Antiquity

The medicinal and nutritional use of grapes (Vitis vinifera) in the ancient Mediterranean world predates recorded history. Various African, Asian, and pre-Columbian cultures, among others, have understood the healing powers of many plants from ancestral knowledge, with anthocyanin-rich plant preparations forming a significant part of those traditions. In Greek and Roman medicine, red wine was employed internally for digestive complaints, wound antisepsis, and as a general tonic, and externally as an astringent for wounds and skin conditions. While the active polyphenols responsible for these effects were not individually identified until the modern era, malvidin-3-O-glucoside is now understood to be among the dominant pigments and bioactive constituents of these preparations.

4.3 Bilberry and Berry Traditions in Northern Europe

Bilberry (Vaccinium myrtillus), a significant source of malvidin glycosides alongside other anthocyanins, has a long documented use in European herbal medicine. Its ripe fruit and leaf were employed by traditional practitioners for gastrointestinal complaints (particularly diarrhea), urinary tract problems, and visual disturbances. The preparation most commonly used historically was a decoction or dried fruit, consumed as food or in tea form.

4.4 Food and Color Use Across Cultures

Since the advent of science and research, it has been found that the curative benefits of plants come from a high content of secondary metabolites such as anthocyanins, flavonoids, terpenes, and phenols, among many other compounds, whose biological and pharmacological activity has been proven. The deep-purple pigmentation contributed by malvidin and related anthocyanins was used as a food colorant across cultures long before the isolation of the compound. Grape-skin extracts and elderberry preparations have been applied as natural dyes in foods and textiles for centuries in European and Asian cultures.

4.5 Isolation of Malvidin as a Discrete Compound

The formal identification of malvidin as a distinct chemical entity dates to the early twentieth century, during the classical era of anthocyanin chemistry. Malvidin and its glycosides are primary plant pigments playing an important role in protecting plants from microbial infection and UV irradiation. Malvidin is responsible primarily for the color, and is included in the polyphenols of red wine together with other anthocyanidins, phenolic acids, flavonoids, and trihydroxy stilbenes.

5. Key Constituents and Active Compounds

There are more than 1,000 types of anthocyanins in nature, all derived from 27 anthocyanidin aglycones that have different glycosylations and acylations. Malvidin's pharmacological activity is principally attributable to the aglycone itself and its major glycosides, primarily malvidin-3-O-glucoside and malvidin-3-O-galactoside.

The structural features that underpin malvidin's biological activity include:

• The flavylium (benzopyrylium) cation core, shared with all anthocyanidins, which enables electron delocalization and free-radical scavenging.
• The two methoxy groups at the 3′ and 5′ positions of the B-ring, which distinguish malvidin from delphinidin and influence its interactions with enzymes and cellular receptors.
• The conjugated double-bond system across the A, B, and C rings, which is responsible for both chromophoric properties and antioxidant capacity through electron donation.

The breakdown of malvidin releases syringic acid, which is itself a phenolic acid with biological activity. This degradation product is also an indicator used in archaeochemical analysis of ancient beverages.

6. Mechanisms of Action

6.1 Antioxidant Mechanisms

The Keap1-Nrf2 system helps protect cellular components from oxidative damage caused by reactive oxygen species (ROS) by increasing antioxidant enzyme expression and decreasing sensitivity to oxidative-stress-related inflammatory reactions. Additionally, Nrf2 promotes the activation of the pentose phosphate pathway (PPP), leading to NADPH production, which is involved in regenerating reduced glutathione (GSH) from GSH disulfide and maintaining cellular antioxidant levels. Therefore, enhancing Nrf2 induction efficiency provides homeostatic mechanisms for the antioxidant activity of malvidin and its glycosides.

Although in earlier studies the biological activities of anthocyanins were closely related to their antioxidant properties, mainly ascribed to the B-ring hydroxyl groups and the conjugated double bond system, their anti-inflammatory and antiatherogenic effects cannot be explained solely on the basis of these properties. There is a plethora of work indicating other action mechanisms, namely by interfering with crucial signaling pathways and gene regulation.

6.2 Anti-inflammatory Mechanisms

The anti-inflammatory activity of malvidin was assessed by its inhibiting enzymes, specifically COX-1 and COX-2. Malvidin is one of the six most prominent anthocyanins found in various fruits and vegetables and may possess a wide range of health-promoting properties. The cyclooxygenase inhibitory activity of malvidin and its glucoside and diglucoside forms has been investigated both in enzymatic assays and via molecular docking. The potential anti-inflammatory activity of malvidin, malvidin-3-glucoside, and malvidin-3,5-diglucoside was demonstrated on the basis of inhibition of COX activity.

It is possible that malvidin and its derivatives, similarly to steroidal anti-inflammatory drugs, stimulate protein kinases PKC, PTK, and MAPK and down-regulate the expression of iNOS, TNF-α, and IL-1β.

6.3 Anti-apoptotic and Endothelial Protection

Studies have shown that anthocyanins possessing either catecholic or monophenolic structures are able to counteract peroxynitrite-induced endothelial cell apoptosis through the inhibition of crucial signaling cascades, upstream and downstream of mitochondria.

6.4 Insulin-Secretory Mechanism

A 2025 study in Scientific Reports examined malvidin-3-glucoside's (M3G) effect on pancreatic β-cells. It enhanced insulin secretion under both basal (4 mM) and stimulatory (11 mM) glucose conditions while maintaining cell viability at concentrations up to 100 µM. Pharmacological inhibitors revealed that M3G-induced Ca²⁺ signals resulted from both Ca²⁺ influx through L-type voltage-dependent calcium channels (L-type VDCCs) and Ca²⁺ release from the endoplasmic reticulum. This suggests a PLC/IP3-dependent pathway underlying malvidin's antidiabetic effects at the pancreatic level.

6.5 Anticancer Mechanisms

Malvidin and its glycosides were found to induce apoptosis, autophagy, cell cycle arrest, suppression of cell proliferation, and prevent metastasis through modulation of various signaling pathways. These include modulation of cell cycle regulatory proteins such as upregulation of p21^WAF1 and induction of G2/M arrest, as reported in human colorectal HCT-116 cancer cells.

6.6 Cholinesterase Inhibition

Anti-inflammatory activity was assessed by inhibiting the enzymes COX-1 and COX-2. Additionally, the inhibitory effects on cholinesterase activity, particularly acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), were evaluated in a dedicated in vitro and molecular docking study. Research clearly supports that malvidin possesses antioxidant activity by inhibiting acetylcholinesterase and managing oxidative stress in neuronal cells. Inhibition of these enzymes is relevant to Alzheimer's disease pathology.

7. Scientific Evidence by Area of Use

7.1 Cardiovascular Health

Prospective and observational studies strongly suggest that grapes and grape products reduce major cardiovascular risk factors. Malvidin-3-O-glucoside, an anthocyanidin polyphenol, is a highly biologically active polyphenol component present in red grape skin and red wine and may have significant effects on cardiovascular risk factors.

The American Heart Association (AHA) recommended moderate red wine consumption and a colored fruit-rich diet to protect the cardiovascular system. Polyphenols such as resveratrol, phenolic acids, anthocyanins, and flavonoids in grapes and grape skin possess potent antioxidant properties and may decrease LDL cholesterol oxidation and platelet aggregation, and promote cardioprotective and vasoprotective properties including antiatherosclerotic, antiarrhythmic, and vasorelaxation actions.

Malvidin-3-glucoside has been shown to point to health benefits including reduction of the incidence of cardiovascular diseases through the inhibition of the oxidation of human low-density lipoproteins.

The anti-inflammatory effects of malvidin may at least partially account for the positive effects of moderate red wine consumption on inflammation-mediated chronic maladies such as obesity, diabetes, hypertension, and cardiovascular disease.

Evidence quality: Much of the cardiovascular evidence for malvidin specifically derives from in vitro and animal studies, supplemented by epidemiological associations between red wine polyphenol consumption and cardiovascular outcomes. Controlled human trials isolating malvidin as a single agent are limited. Most human evidence is confounded by the simultaneous presence of resveratrol, other anthocyanins, and alcohol in tested beverages.

7.2 Antidiabetic Effects

Several studies, including those conducted on cell lines, animals, and humans, have suggested that malvidin and its glycosides possess diabetes-control properties.

Among the mechanisms investigated, α-glucosidase inhibition is one of the most studied in enzymatic assays. The α-glucosidase inhibitory potentials of anthocyanin aglycones were determined as delphinidin > cyanidin > petunidin > peonidin > pelargonidin > malvidin. They exhibited lower inhibition compared with acarbose, and the IC₅₀ values were between 4.11 and 54.69 µM. This indicates malvidin is among the weakest α-glucosidase inhibitors within the anthocyanidin group, a consequence of its B-ring methoxy substitution.

However, malvidin's antidiabetic activity likely operates through multiple pathways. The 2025 Scientific Reports study demonstrated that malvidin-3-glucoside activates the PLC/IP3 pathway, enhancing calcium influx to stimulate insulin secretion in INS-1 pancreatic β-cells. It enhanced insulin secretion under both basal and stimulatory glucose conditions while maintaining cell viability at concentrations up to 100 µM.

In oxidative stress models relevant to diabetes, the production of ROS is triggered by hyperglycemia and is believed to play a role in the pathogenesis of disease. Elevated glucose levels are known to induce oxidative stress by upregulating mitochondrial ROS, causing protein glycation, and triggering glucose autooxidation, processes which can impair enzyme activity and cellular function. Malvidin's antioxidant mechanisms are considered relevant to countering these diabetes-associated oxidative pathways.

Evidence quality: Predominantly in vitro and animal data. Human clinical trials specifically examining malvidin for glycemic control are not established in the peer-reviewed literature as of the time of this writing.

7.3 Neuroprotection and Cognitive Function

Studies have noted the exhibited neuroprotective properties of malvidin and its anthocyanin glycosides, attributable to the prevention of mitochondrial dysfunction and the accumulation of reactive oxygen species (ROS), whilst enhancing antioxidant enzyme activity within the cerebrum.

An animal study evaluated malvidin against aluminum chloride-induced neurotoxicity in rats. The rats were divided into four groups: one received saline, one received AlCl₃, and two were administered malvidin at 100 mg/kg and 200 mg/kg after AlCl₃ for 60 days. Malvidin ameliorated the effects of AlCl₃ on behavioral parameters, and biochemical investigation revealed that oral treatment of malvidin shows neuroprotective effects through regulation of antioxidant levels and neuroinflammation in AlCl₃-exposed rats.

Research clearly supports that malvidin possesses antioxidant activity by inhibiting acetylcholinesterase and managing oxidative stress in neuronal cells, an effect with relevance to dementia and Alzheimer's disease models.

In a human trial context relevant to anthocyanin-rich supplementation, a human trial supplemented with 25 g of blueberry powder found participants reported significantly fewer cognitive symptoms and improved memory discrimination, suggesting a potential benefit of anthocyanin supplementation. Malvidin is among the anthocyanins present in blueberry, though this study did not isolate malvidin as the active agent.

Evidence quality: Animal and in vitro data are promising. The human blueberry study cited is relevant but cannot be attributed specifically to malvidin in isolation. Dedicated clinical trials on malvidin for neurological outcomes are not yet reported.

7.4 Anticancer Activity

Malvidin and its glycosides have been studied for their anti-carcinogenic potential in various forms of cancer. The available review provides an in-depth analysis of the anti-carcinogenic potential of malvidin and its glycosides in cancer types such as leukemia, colon/colorectal, gastric, hepatocarcinoma, lung, oral, and breast cancer.

Malvidin displays anti-carcinogenic activity by reducing proliferation, metastasis, and enhancing autophagy and apoptosis in different in vitro and in vivo cancer models. In human colorectal HCT-116 cancer cells specifically, malvidin has been reported to induce apoptosis and G2/M cell cycle arrest and upregulation of p21^WAF1. Malvidin and its glycosides were found to induce apoptosis, autophagy, cell cycle arrest, suppression of cell proliferation, and prevent metastasis through modulation of various signaling pathways.

However, there is currently a lack of unequivocal human trials allowing for the assessment of the anticancer effect of malvidin.

Further in-depth in vitro, in vivo, and human studies must be conducted to reveal the actual potential of malvidin against cancer.

Evidence quality: The anticancer evidence for malvidin is currently limited to in vitro cell-line studies and animal models. No human clinical trials have been conducted specifically on malvidin as an anticancer agent. The current evidence base is preliminary and hypothesis-generating only.

7.5 Anti-inflammatory Effects

A 2013 study by Bognar et al. from the University of Pécs examined malvidin's effects in LPS-stimulated RAW264.7 macrophages, a widely used model of acute inflammation. Red wine polyphenols can prevent cardiovascular and inflammatory diseases. Resveratrol, the most extensively studied constituent, is unlikely to solely account for these beneficial effects because of its rather low abundance and bioavailability, suggesting malvidin may contribute meaningfully. The study concluded that malvidin's effects may account for the positive effects of moderate red wine consumption on inflammation-mediated chronic maladies.

In a combined in vitro and molecular docking investigation, the study selected malvidin and its two sugar derivatives (malvidin-3-O-glucoside and malvidin-3,5-O-diglucoside), and anti-inflammatory activity was assessed by inhibiting the enzymes COX-1 and COX-2. Molecular modeling was also employed to examine and visualize the interactions between these enzymes and the anthocyanins, confirming molecular-level anti-inflammatory potential.

Evidence quality: Well-characterized at the in vitro and mechanistic levels. Human clinical evidence for malvidin specifically as an anti-inflammatory agent is absent; the preponderance of evidence involves cell cultures and animal models.

7.6 Cadmium-Induced Reproductive Toxicity Protection

In human ovarian granulosa-like tumor cells (KGN), malvidin-3-O-glucoside (M3G) lessened cadmium-induced cytotoxicity and significantly decreased the Cd-induced generation of reactive oxygen species, inhibited Cd-induced arrest of the G2/M phase of the cell cycle, and increased estradiol (E2) production. These findings indicated that M3G has great potential to prevent Cd-induced female reproductive impairment as a dietary supplement. This evidence is currently in vitro only.

8. Bioavailability, Absorption, and Metabolism

Following consumption, anthocyanin absorption occurs along the gastrointestinal tract, the distal lower bowel being the place where most of the absorption and metabolism occurs. In the intestine, anthocyanins first undergo extensive microbial catabolism followed by absorption and human phase II metabolism. This produces hybrid microbial–human metabolites which are absorbed and subsequently increase the bioavailability of anthocyanins.

A key early human bioavailability study by Bub et al. (2001) in the European Journal of Nutrition examined malvidin-3-glucoside (M-3-G) absorption from three beverages in six healthy male volunteers in a randomized crossover design. Six healthy male subjects were studied in a randomized crossover setting; all subjects consumed 500 mL of each beverage on separate days providing the following M-3-G quantities: red wine 68 mg, dealcoholized red wine 58 mg, and red grape juice 117 mg. M-3-G was found in plasma and urine after ingestion of all the beverages studied. Increases in plasma M-3-G concentrations were not significantly different after consumption of either red wine or dealcoholized red wine and were about two times less than those measured after consumption of red grape juice, likely because of the approximately two times higher M-3-G concentration in red grape juice.

Areas under the plasma concentration curves were as follows: 288 ± 127 nmol×h/L (red wine), 214 ± 124 nmol×h/L (dealcoholized red wine), and 662 ± 210 nmol×h/L (red grape juice), showing a linear relationship with the amount of anthocyanin consumed.

M-3-G is poorly absorbed after a single ingestion of red wine, dealcoholized red wine, or red grape juice. The aglycone, sulfate, or glucuronate conjugates of M-3-G were not detected in plasma and urine under those conditions, suggesting the intact glycoside was absorbed but not extensively phase-II metabolized at detectable levels in that study.

Studies investigating anthocyanin absorption by Caco-2 cells report very low absorption of these compounds. However, the bioavailability of anthocyanins may be underestimated since the metabolites formed in the course of digestion could be responsible for the health benefits associated with anthocyanins.

Anthocyanins including malvidin show low chemical stability and a short half-life and relatively low bioavailability, since they are easily degraded due to being affected by pH, temperature, ascorbic acid, light, oxygen, enzymes, and metallic ions.

9. Dosage Forms and Dosages Reported in Studies

Malvidin is not standardized as a pharmaceutical ingredient or an approved isolated dietary supplement in most regulatory jurisdictions. It is encountered primarily as a component of grape-skin extracts, bilberry extracts, and anthocyanin-rich fruit preparations. The following dosages are those reported specifically in the scientific literature:

• Human bioavailability study (Bub et al., 2001): All subjects consumed 500 mL of each beverage on separate days providing the following M-3-G quantities: red wine 68 mg, dealcoholized red wine 58 mg, and red grape juice 117 mg.
• Blueberry powder, human cognitive study: A human trial supplemented with 25 g of blueberry powder found significantly fewer cognitive symptoms and improved memory discrimination. The malvidin content of this dose was not isolated in the cited review.
• Animal neuroprotection (aluminum chloride model): Rats were administered malvidin at doses of 100 mg/kg and 200 mg/kg after AlCl₃ for 60 days.
• Acute toxicity testing (OECD guideline): The test drug (malvidin) was administered up to the limit dose of 2,000 mg/kg in male rats following OECD guideline acute toxicity study no. 425 (up and down procedure), with animals observed for 14 days for signs of toxicity.
• In vitro insulin secretion study (Scientific Reports, 2025): Malvidin-3-glucoside enhanced insulin secretion while maintaining cell viability at concentrations up to 100 µM.

No human clinical trial has established a defined therapeutic or supplemental dose of isolated malvidin.

10. Body Systems and Health Areas of Association

Based on the available in vitro, animal, and limited human evidence, malvidin and its glycosides are associated with the following body systems and health areas:

• Cardiovascular system: Inhibition of LDL oxidation, modulation of endothelial nitric oxide synthase activity, reduction of platelet aggregation, and antiatherosclerotic properties.
• Endocrine and metabolic system: Antidiabetic activity via multiple mechanisms including insulin secretion stimulation (PLC/IP3/Ca²⁺ pathway), α-glucosidase inhibition, and mitigation of hyperglycemia-induced oxidative stress.
• Central nervous system and neuroprotection: Prevention of mitochondrial dysfunction, reduction of ROS accumulation, inhibition of acetylcholinesterase and butyrylcholinesterase, and protection against neurotoxin-induced behavioral deficits in animal models.
• Oncological (preclinical): Induction of apoptosis, autophagy, cell cycle arrest, and inhibition of proliferation and metastasis across multiple cancer cell line types in vitro.
• Immune and inflammatory system: Inhibition of COX-1 and COX-2, downregulation of pro-inflammatory cytokines (TNF-α, IL-1β), and modulation of NF-κB and MAPK signaling pathways.
• Reproductive system: Protective effects against heavy-metal-induced reproductive toxicity in ovarian granulosa cell models (in vitro).

It can be concluded that malvidin and its glycosides possess significant anticancer, cardioprotective, antidiabetic, and neuroprotective properties due to their antioxidant and anti-inflammatory mechanisms of action. Various studies, including in vitro and in vivo, suggest that these molecules have the potential to counteract the onset and progression of several disease pathologies, in particular those with pathogenesis related to oxidative stress.

11. Safety Considerations and Known Interactions

11.1 General Safety Profile

Anthocyanins including malvidin and its glycosides are naturally abundant and pose no harm to consumers, making them desirable as natural color additives. At dietary exposure levels encountered through consumption of red wine, grapes, and berries, malvidin glycosides are not associated with adverse effects in healthy individuals.

In acute toxicity testing conducted according to OECD guidelines, the test drug (malvidin) was administered up to the limit dose of 2,000 mg/kg in male rats, with the animals observed for the next 14 days for signs of toxicity. This limit-dose study, the standard approach for substances expected to have low acute toxicity, suggests a high acute oral safety margin in rodents; however, human equivalence studies have not been formally reported.

11.2 Stability Limitations as a Supplement

Anthocyanins offer nutritional and pharmacological effects, but their stability is poor. Malvidin-containing anthocyanins show low chemical stability and a short half-life and are easily degraded by pH changes, temperature, ascorbic acid, light, oxygen, enzymes, and metallic ions. This property has practical implications for supplement formulation: the bioactive concentration of malvidin in commercially prepared extracts may be substantially lower than stated if not stored and formulated appropriately.

11.3 Bioavailability Considerations

M-3-G is poorly absorbed after a single ingestion of red wine, dealcoholized red wine, or red grape juice. The low absolute bioavailability of intact malvidin glycosides means that the concentrations required to produce in vitro effects may not be reliably attained in systemic circulation from dietary intake. The relevance of in vitro findings to human physiology is therefore limited by this pharmacokinetic consideration.

11.4 Food and Drug Interactions

No formal drug interaction studies for isolated malvidin have been reported in the peer-reviewed literature. Given that malvidin glycosides inhibit COX enzymes in vitro, the potential anti-inflammatory activity of malvidin was proved on the basis of inhibition of COX activity, a theoretical pharmacodynamic interaction with NSAIDs or anticoagulants via shared mechanisms cannot be excluded, but has not been formally documented.

11.5 Regulatory Status

Anthocyanins extracted from plants have been used as food additives; food additive E163 is one of the commercial additives derived from fruit anthocyanins such as grape skin. Malvidin-containing extracts sold under this designation are regulated as food colorants in the European Union. Malvidin as an isolated supplement ingredient does not have an established monograph in major pharmacopeias or a defined acceptable daily intake (ADI) from EFSA or the WHO.

11.6 Remaining Research Gaps

Further research is needed to fully understand the molecular mechanisms responsible for the health effects of malvidin and its glycosides and to explore potential new applications for these compounds. The biological activity of malvidin and its glycosides is not entirely clear and has been relatively less frequently studied compared to other anthocyanins. The most significant research gap is the near-total absence of randomized controlled trials in humans studying isolated malvidin supplementation for any health outcome.

References

• Iqbal K. et al. (2023). Food Anthocyanins: Malvidin and Its Glycosides as Promising Antioxidant and Anti-Inflammatory Agents with Potential Health Benefits. Nutrients. PubMed/PMC 10346481.
• Iqbal K. et al. (2023). Food Anthocyanins: Malvidin and Its Glycosides (Full text). PMC 10346481.
• Baj A. et al. (2004). Comparison of HPLC methods for determination of anthocyanins and anthocyanidins in bilberry extracts. PubMed 14969517.
• Mattioli R. et al. (2020). Anthocyanins: A Comprehensive Review of Their Chemical Properties and Health Effects on Cardiovascular and Neurodegenerative Diseases. Molecules. PubMed 32825684.
• Mattioli R. et al. (2020). Anthocyanins: A Comprehensive Review (Full text). PMC 7504512.
• Malinowska J. et al. (2023). Malvidin and Its Mono- and Di-Glucosides Forms: COX and Cholinesterase Activities. PMC 10708353.
• Neves A.R. et al. (2012). Protective Role of Malvidin-3-Glucoside on Peroxynitrite-Induced Damage in Endothelial Cells. PMC 3388314.
• Bognar E. et al. (2013). Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol. PMC 3673972.
• Bub A. et al. (2001). Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur J Nutr. PubMed 11697443.
• Khoo H.E. et al. (2020). The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action. PMC 7479177.
• Chauhan T. et al. (2024). Potential anti-cancer properties of malvidin and its glycosides: Evidence from in vitro and in vivo studies. Journal of Functional Foods. ScienceDirect.
• Ganesan K. et al. (2022). Antiamnesic Potential of Malvidin on Aluminum Chloride Activated by the Free Radical Scavenging Property. ACS Omega.
• Xu Y. et al. (2023). Malvidin-3-O-Glucoside Ameliorates Cadmium-Mediated Cell Dysfunction in Estradiol Generation of Human Granulosa Cells. PMC 9921828.
• Fernandes I. et al. (2015). Anthocyanin Absorption and Metabolism by Human Intestinal Caco-2 Cells—A Review. PMC 4613267.
• Gök V. et al. (2023). Advances in the Chemistry, Analysis and Adulteration of Anthocyanin Rich-Berries and Fruits: 2000–2022. PMC 9865467.
• Khoo H.E. et al. (2022). Anthocyanins: Traditional Uses, Structural and Functional Variations, Approaches to Increase Yields and Products' Quality, Hepatoprotection, Liver Longevity. PMC 8875224.
• PubChem. Malvidin. CID 159287. National Institutes of Health.
• Wikipedia. Malvidin (chemical identity, historical sources, syringic acid degradation).
• ScienceDirect Topics. Malvidin — Overview. Cardiovascular risk factors and AHA context.
• Channuwong P. et al. (2025). Malvidin-3-glucoside induces insulin secretion by activating the PLC/IP3 pathway. Scientific Reports.
• Şöhretoğlu D. et al. (2023). Advances in the natural α-glucosidase inhibitors. eFood. Wiley.
• Faria A. et al. (2022). Malvidin: Advances in the Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology. Springer Nature Link.
• Nassiri-Asl M. & Hosseinzadeh H. (2016). Advanced Knowledge of Three Important Classes of Grape Phenolics: Anthocyanins, Stilbenes and Flavonols. PMC 3821578.
• He J. & Giusti M.M. (2017). Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits. PMC 5613902.